American Heart Association
DECLARing Impact Beyond SELECT Trials: Real World Effects of Cardioprotective Anti-Hyperglycemic Agents
Moderated Digital Poster Session
Zone 3, Moderated Digital Poster 13
Nov 17th , 09:30 AM - 10:55 AM
09 : 30 AM
Glucagon-like Peptide-1 Receptor Agonists for the Primary Prevention of Major Adverse Cardiac Events in Drug-naïve Type 2 Diabetes: A Propensity-score Analysis
Chi Kuan Yu, Chang Yu, Nanna, Md, Facc Michele, Nanna Michael, Lee Pei-lun, Osabutey Anita, Borkowski Pawel, Song Junmin, Akman Zafer, Romero Acero Laura, Maliha Maisha, Satish Vikyath
Final Pr. ID: MDP1018
Authors: Chi Kuan Yu, Chang Yu, Nanna, Md, Facc Michele, Nanna Michael, Lee Pei-lun, Osabutey Anita, Borkowski Pawel, Song Junmin, Akman Zafer, Romero Acero Laura, Maliha Maisha, Satish Vikyath
Keywords: Diabetes Mellitus , Cardiovascular disease prevention , Obesity , Heart failure
09 : 40 AM
Combined use of cardioprotective glucose-lowering drugs and statins in individuals with type 2 diabetes is associated with the lowest risk of all-cause mortality
Ternhamar Tummas, Johansen Mia, Nordestgaard Borge, Afzal Shoaib
Final Pr. ID: MDP1019
Authors: Ternhamar Tummas, Johansen Mia, Nordestgaard Borge, Afzal Shoaib
Keywords: Diabetes (Type II) , Cardioprotective drugs , Statins , Epidemiology
09 : 50 AM
Persistence to once weekly GLP-1 RAs is associated with lower risk of MI, stroke, and 2-point MACE among patients with T2D and ASCVD in the real world.
Dunn Tyler, Zhu Yong, Gronroos Noelle, Xie Lin, Noone Josh, Sargent Andrew, Gamble Cory, Billings Liana
Final Pr. ID: MDP1020
Authors: Dunn Tyler, Zhu Yong, Gronroos Noelle, Xie Lin, Noone Josh, Sargent Andrew, Gamble Cory, Billings Liana
Keywords: Diabetes (Type II) , Cardiovascular disease , Myocardial infarction , Stroke
10 : 00 AM
Safety, Efficacy and Cardiovascular Benefits of Combination Therapy with Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Mousavi Asma, Syed Mushabbar, Kampaktsis Polydoros, Kuno Toshiki, Heffron Sean, Samsky Marc, Khorsand Askari Mani, Hosseini Kaveh, Shojaei Shayan, Soleimani Hamidreza, Semirani-nezhad Davood, Ebrahimi Pouya, Zafari Ali, Ebrahimi Rasoul, Roozbehi Khatere, Harrison Anil
Final Pr. ID: MDP1021
Authors: Mousavi Asma, Syed Mushabbar, Kampaktsis Polydoros, Kuno Toshiki, Heffron Sean, Samsky Marc, Khorsand Askari Mani, Hosseini Kaveh, Shojaei Shayan, Soleimani Hamidreza, Semirani-nezhad Davood, Ebrahimi Pouya, Zafari Ali, Ebrahimi Rasoul, Roozbehi Khatere, Harrison Anil
Keywords: Cardiovascular Risk , Heart failure
10 : 10 AM
Impact Of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like-Peptide-1 Agonists On Cardiovascular and Renal Outcomes In Patients With Type 2 Diabetes Mellitus (T2DM) and Autoimmune Diseases: A Global Retrospective Study
Anuforo Anderson, Kadel Anuj, Sandhu Prabhjeet, Draytsel Dan, Melfi Michelle, Perl Andras, Taub Cynthia, Somerville Alexander, Bhandari Jenish, Sherazi Mahnoor, Gautam Kamal, Olojakpoke Eloho, Awoyemi Toluwalase, Makri Helena, Poudyal Bhavya
Final Pr. ID: MDP1022
Authors: Anuforo Anderson, Kadel Anuj, Sandhu Prabhjeet, Draytsel Dan, Melfi Michelle, Perl Andras, Taub Cynthia, Somerville Alexander, Bhandari Jenish, Sherazi Mahnoor, Gautam Kamal, Olojakpoke Eloho, Awoyemi Toluwalase, Makri Helena, Poudyal Bhavya
Keywords: Autoimmune , Diabetes (Type II) , Cardiac Thromboembolism , Mortality , Outcomes
10 : 20 AM
Suicide and Self-Harm with GLP-1 Receptor Agonists: A Meta-Analysis of Randomized Controlled Trials
Hosseini Kaveh, Heffron Sean, Ebrahimi Pouya, Batlle Juan, Maqsood Muhammad Haisum, Ayati Aryan, Long Clarine, Mcgowan Natalie, Tarabanis Constantine, Laynor Gregory
Final Pr. ID: MDP1023
Authors: Hosseini Kaveh, Heffron Sean, Ebrahimi Pouya, Batlle Juan, Maqsood Muhammad Haisum, Ayati Aryan, Long Clarine, Mcgowan Natalie, Tarabanis Constantine, Laynor Gregory
Keywords: Weight loss , Diabetes (Type II)
10 : 30 AM
SGLT2 Inhibitors and Diabetic Retinopathy: Reducing Surgical Interventions and Vision Loss
Akbar Usman, Cheshire Michael, Umer Ahmed Muaaz, Shafique Nouman, Muhibullah Fnu, Akbar Ayesha, Naveed Muhammad Abdullah, Ahmed Faizan, Khan Muhammad Aslam, Sohail Hadia
Final Pr. ID: MDP1024
Authors: Akbar Usman, Cheshire Michael, Umer Ahmed Muaaz, Shafique Nouman, Muhibullah Fnu, Akbar Ayesha, Naveed Muhammad Abdullah, Ahmed Faizan, Khan Muhammad Aslam, Sohail Hadia
Keywords: Atherosclerosis , Vasculogenesis
10 : 40 AM
Glucagon-like Peptide-1 Receptor Agonist Use and Cardiac Outcomes in Patients with End Stage Kidney Disease
Catanese Benjamin, Miller Cameron, Wolf Myles, Edmonston Daniel
Final Pr. ID: MDP1025
Authors: Catanese Benjamin, Miller Cameron, Wolf Myles, Edmonston Daniel
Keywords: Cardiovascular Risk , Mortality , Big Data , Cardiovascular disease , Kidney Disease
09 : 40 AM
Combined use of cardioprotective glucose-lowering drugs and statins in individuals with type 2 diabetes is associated with the lowest risk of all-cause mortality
Ternhamar Tummas, Johansen Mia, Nordestgaard Borge, Afzal Shoaib
Final Pr. ID: MDP1019
Authors: Ternhamar Tummas, Johansen Mia, Nordestgaard Borge, Afzal Shoaib
Keywords: Diabetes (Type II) , Cardioprotective drugs , Statins , Epidemiology
10 : 40 AM
Glucagon-like Peptide-1 Receptor Agonist Use and Cardiac Outcomes in Patients with End Stage Kidney Disease
Catanese Benjamin, Miller Cameron, Wolf Myles, Edmonston Daniel
Final Pr. ID: MDP1025
Authors: Catanese Benjamin, Miller Cameron, Wolf Myles, Edmonston Daniel
Keywords: Cardiovascular Risk , Mortality , Big Data , Cardiovascular disease , Kidney Disease
09 : 30 AM
Glucagon-like Peptide-1 Receptor Agonists for the Primary Prevention of Major Adverse Cardiac Events in Drug-naïve Type 2 Diabetes: A Propensity-score Analysis
Chi Kuan Yu, Chang Yu, Nanna, Md, Facc Michele, Nanna Michael, Lee Pei-lun, Osabutey Anita, Borkowski Pawel, Song Junmin, Akman Zafer, Romero Acero Laura, Maliha Maisha, Satish Vikyath
Final Pr. ID: MDP1018
Authors: Chi Kuan Yu, Chang Yu, Nanna, Md, Facc Michele, Nanna Michael, Lee Pei-lun, Osabutey Anita, Borkowski Pawel, Song Junmin, Akman Zafer, Romero Acero Laura, Maliha Maisha, Satish Vikyath
Keywords: Diabetes Mellitus , Cardiovascular disease prevention , Obesity , Heart failure
10 : 10 AM
Impact Of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like-Peptide-1 Agonists On Cardiovascular and Renal Outcomes In Patients With Type 2 Diabetes Mellitus (T2DM) and Autoimmune Diseases: A Global Retrospective Study
Anuforo Anderson, Kadel Anuj, Sandhu Prabhjeet, Draytsel Dan, Melfi Michelle, Perl Andras, Taub Cynthia, Somerville Alexander, Bhandari Jenish, Sherazi Mahnoor, Gautam Kamal, Olojakpoke Eloho, Awoyemi Toluwalase, Makri Helena, Poudyal Bhavya
Final Pr. ID: MDP1022
Authors: Anuforo Anderson, Kadel Anuj, Sandhu Prabhjeet, Draytsel Dan, Melfi Michelle, Perl Andras, Taub Cynthia, Somerville Alexander, Bhandari Jenish, Sherazi Mahnoor, Gautam Kamal, Olojakpoke Eloho, Awoyemi Toluwalase, Makri Helena, Poudyal Bhavya
Keywords: Autoimmune , Diabetes (Type II) , Cardiac Thromboembolism , Mortality , Outcomes
09 : 50 AM
Persistence to once weekly GLP-1 RAs is associated with lower risk of MI, stroke, and 2-point MACE among patients with T2D and ASCVD in the real world.
Dunn Tyler, Zhu Yong, Gronroos Noelle, Xie Lin, Noone Josh, Sargent Andrew, Gamble Cory, Billings Liana
Final Pr. ID: MDP1020
Authors: Dunn Tyler, Zhu Yong, Gronroos Noelle, Xie Lin, Noone Josh, Sargent Andrew, Gamble Cory, Billings Liana
Keywords: Diabetes (Type II) , Cardiovascular disease , Myocardial infarction , Stroke
10 : 00 AM
Safety, Efficacy and Cardiovascular Benefits of Combination Therapy with Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Mousavi Asma, Syed Mushabbar, Kampaktsis Polydoros, Kuno Toshiki, Heffron Sean, Samsky Marc, Khorsand Askari Mani, Hosseini Kaveh, Shojaei Shayan, Soleimani Hamidreza, Semirani-nezhad Davood, Ebrahimi Pouya, Zafari Ali, Ebrahimi Rasoul, Roozbehi Khatere, Harrison Anil
Final Pr. ID: MDP1021
Authors: Mousavi Asma, Syed Mushabbar, Kampaktsis Polydoros, Kuno Toshiki, Heffron Sean, Samsky Marc, Khorsand Askari Mani, Hosseini Kaveh, Shojaei Shayan, Soleimani Hamidreza, Semirani-nezhad Davood, Ebrahimi Pouya, Zafari Ali, Ebrahimi Rasoul, Roozbehi Khatere, Harrison Anil
Keywords: Cardiovascular Risk , Heart failure
10 : 30 AM
SGLT2 Inhibitors and Diabetic Retinopathy: Reducing Surgical Interventions and Vision Loss
Akbar Usman, Cheshire Michael, Umer Ahmed Muaaz, Shafique Nouman, Muhibullah Fnu, Akbar Ayesha, Naveed Muhammad Abdullah, Ahmed Faizan, Khan Muhammad Aslam, Sohail Hadia
Final Pr. ID: MDP1024
Authors: Akbar Usman, Cheshire Michael, Umer Ahmed Muaaz, Shafique Nouman, Muhibullah Fnu, Akbar Ayesha, Naveed Muhammad Abdullah, Ahmed Faizan, Khan Muhammad Aslam, Sohail Hadia
Keywords: Atherosclerosis , Vasculogenesis
10 : 20 AM
Suicide and Self-Harm with GLP-1 Receptor Agonists: A Meta-Analysis of Randomized Controlled Trials
Hosseini Kaveh, Heffron Sean, Ebrahimi Pouya, Batlle Juan, Maqsood Muhammad Haisum, Ayati Aryan, Long Clarine, Mcgowan Natalie, Tarabanis Constantine, Laynor Gregory
Final Pr. ID: MDP1023
Authors: Hosseini Kaveh, Heffron Sean, Ebrahimi Pouya, Batlle Juan, Maqsood Muhammad Haisum, Ayati Aryan, Long Clarine, Mcgowan Natalie, Tarabanis Constantine, Laynor Gregory
Keywords: Weight loss , Diabetes (Type II)